{
    "2014-06-11": [
        "PFE Pfizer Announces Over 10 Abstracts for XELJANZ (Tofacitinib Citrate) in Rheumatoid Arthritis",
        "Reason PFE only named 1 of 4 tgts chosen for halo -its in its interest to declare monthly dosing for RN-316-now it wants 2 lower",
        "Keeping my Eye on PFE TTC EXC CBM economy"
    ]
}